结论孟鲁司特钠在慢性阻塞性肺病治疗中临床疗效显著。
Conclusion the clinical efficacy of Montelukast Sodium in the treatment of chronic obstructive pulmonary disease is obvious.
世卫组织支持会员国致力减少慢性阻塞性肺病的危害，并协调国际努力改善全球呼吸道健康，尤其是在中低收入国家。
WHO supports Member States as they work to reduce the toll of COPD and coordinates international efforts to improve global respiratory health, particularly in middle- and low-income countries.
在使用烟草几十年后，她出现了慢性阻塞性肺病。
After decades of tobacco use, chronic obstructive pulmonary disease (COPD) developed.
原因：慢性阻塞性肺病(COPD)在中国的患病率多数人不知。
Rationale: The prevalence of chronic obstructive pulmonary disease (COPD) in China is largely unknown.
在北京，他们研究了近500名年龄30岁及30岁以上的慢性阻塞性肺病的患者，并对这些患者进行了抑郁和焦虑相关的调查。
They studied nearly 500 COPD patients aged 30 and older in Beijing. The patients completed surveys about depression and anxiety.
评估“医院在家”相较于住院照护在治疗慢性阻塞性肺病急性恶化的效益。
To evaluate the efficacy of hospital at home compared to hospital inpatient care in acute exacerbations of COPD.
研究者们总结到，在总共六个月的减少抗生素使用中，同标准的治疗组相比原降钙素对慢性阻塞性肺病加重病人的知道提供了一个持续的优点。
"Procalcitonin guidance for exacerbations of COPD offers a sustained advantage over standard therapy in reducing antibiotic use for up to 6 months," the researchers conclude.
研究者们总结到，在总共六个月的减少抗生素使用中，同标准的治疗组相比原降钙素对慢性阻塞性肺病加重病人的知道提供了一个持续的优点。
"Procalcitonin guidance for exacerbations of COPD offers a sustained advantage over standard therapy in reducing antibiotic use for up to 6 months," the researchers conclude.
应用推荐